Kimman T G, de Leeuw O, Kochan G, Szewczyk B, van Rooij E, Jacobs L, Kramps J A, Peeters B
Department of Porcine and Exotic Viral Diseases, Institute for Animal Science and Health ID-DLO, Lelystad, The Netherlands.
Clin Diagn Lab Immunol. 1996 Mar;3(2):167-74. doi: 10.1128/cdli.3.2.167-174.1996.
Antibodies in porcine sera against glycoprotein E (gE) of pseudorabies virus (PRV) are usually measured in blocking enzyme-linked immunosorbent assays (ELISAs) with one or two murine monoclonal antibodies (MAbs) directed against gE. Our aim was to develop a confirmation assay which is based on another principle and which is able to detect antibodies directed against most potential binding sites on gE with high specificity. Therefore, we developed an indirect double-antibody sandwich assay (IDAS) using recombinant gE expressed by baculovirus (BacgE960). A fragment of the gE gene consisting of nucleotide positions +60 to +1020 of gE, coding for the major antigenic sites of gE but not the transmembrane region, was cloned behind the signal sequence of PRV gG and the p10 promoter in a baculovirus vector. Immunoblot analysis showed that the expressed protein reacted with MAbs directed against five of the six antigenic sites on gE. Although the conformation of some antigenic sites, notably antigenic sites E and C, was not identical to their natural conformation, the expressed protein bound gE-specific antibodies in porcine sera in Western blots (immunoblots) and ELISAs. For the IDAS, a coating MAb directed against the nonimmunodominant antigenic site A on gE was chosen. A major obstacle in binding ELISAs, such as the IDAS, appeared to be the high nonspecific binding activity observed in porcine sera. As a result, sera could be tested only in relatively high dilutions in the BacgE960 IDAS, in contrast to the testing of sera in blocking ELISAs. The sensitivity and specificity of the newly developed BacgE960 IDAS were evaluated and compared with those of five commercially available blocking ELISAs by using several sets of sera of known PRV disease history. The BacgE960 IDAS assay had a high diagnostic specificity and a moderate sensitivity. The five blocking ELISAs differed remarkably in sensitivity and specificity, thereby illustrating the need for standardization and confirmation. We conclude that the BacgE960 IDAS is a useful and specific additional (confirmatory) test for the detection of antibodies to gE.
通常采用阻断酶联免疫吸附测定(ELISA),使用一两种针对伪狂犬病病毒(PRV)糖蛋白E(gE)的鼠单克隆抗体(MAb)来检测猪血清中针对gE的抗体。我们的目标是开发一种基于另一种原理的确认测定法,该方法能够以高特异性检测针对gE上大多数潜在结合位点的抗体。因此,我们利用杆状病毒表达的重组gE(BacgE960)开发了一种间接双抗体夹心测定法(IDAS)。gE基因的一个片段,由gE核苷酸位置+60至+1020组成,编码gE的主要抗原位点,但不包括跨膜区域,被克隆到杆状病毒载体中PRV gG的信号序列和p10启动子之后。免疫印迹分析表明,表达的蛋白与针对gE六个抗原位点中五个的单克隆抗体发生反应。尽管某些抗原位点,特别是抗原位点E和C的构象与其天然构象不同,但表达的蛋白在Western印迹(免疫印迹)和ELISA中能结合猪血清中的gE特异性抗体。对于IDAS,选择了一种针对gE上非免疫显性抗原位点A的包被单克隆抗体。结合ELISA(如IDAS)中的一个主要障碍似乎是在猪血清中观察到的高非特异性结合活性。结果,与阻断ELISA中血清的检测相比,在BacgE960 IDAS中只能以相对较高的稀释度检测血清。通过使用几组已知PRV疾病史的血清,评估了新开发的BacgE960 IDAS的敏感性和特异性,并与五种市售阻断ELISA的敏感性和特异性进行了比较。BacgE960 IDAS测定法具有高诊断特异性和中等敏感性。五种阻断ELISA在敏感性和特异性上有显著差异,从而说明了标准化和确认的必要性。我们得出结论,BacgE960 IDAS是一种用于检测gE抗体的有用且特异的附加(确认)试验。